Key result
Kaempferol-mediated selenium nanoparticles protect against 5-FU-induced cardiotoxicity, reducing troponin by ~40%.
Why the study?
Dose limiting cardiotoxicity of 5-fluorouracil restricts its therapeutic use, necessitating investigation of cardioprotective strategies.
Does KMP-SeNPs prevent 5-fluorouracil-induced cardiotoxicity in a rat model?
Does KMP-SeNPs prevent 5-fluorouracil-induced cardiotoxicity in a rat model?
p-value: p=<0.05
Kaempferol-mediated selenium nanoparticles demonstrated significant cardioprotective effects against 5-fluorouracil-induced cardiotoxicity in rats through antioxidant, anti-inflammatory, and anti-apoptotic mechanisms.
May protect rat hearts from 5-FU cardiotoxicity; leaves open translation to human cardioprotection.
Abstract 5-Flurouracil (5-FU) is still considered as one of the most popular antimetabolite chemotherapy drugs to treat a wide variety of solid tumors. Dose limiting toxicity on major organs, especially cardiovascular system limits the therapeutic use of 5-FU. The current paper addresses the cardioprotective effect of green synthesized selenium nanoparticles through kaempferol (KMP-SeNPs) on the cardiotoxicity induced by 5-FU in a rat model. 35 male Wistar rats were divided equally into five groups, namely control, 5-FU, Na 2 SeO 3 &5-FU, KMP&5-FU, and KMP-SeNPs&5-FU. The 5-FU consumed 5 days induced cardiotoxicity and there were 21 days of oral treatment. The levels of cardiac injury markers, oxidative stress indices, antioxidant enzymes, inflammatory/anti-inflammatory cytokines and apoptotic markers were measured by ELISA, gene expression and immunohistochemistry. The evaluation of cardiac tissue was done by using histopathology. 5-FU caused significant cardiotoxicity detected by increased cardiac enzymes, oxidative stress, inflammatory cytokines, apoptosis, and extensive histopathologic damage. KMP-SeNPs treatment had a great impact on reducing myocardial injury, normalizing cardiac enzymes, decreasing lipid peroxidation and NO generation, reestablishing antioxidant defenses, and increasing Nrf2 signaling and inhibiting Keap-1 expression. The expression of TNF-α, IL-6, NF-κB, Bax, and caspase-3, were significantly decreased, whereas IL-10, FOXP3, and Bcl-2 showed a significant increase, which is evidence of the great anti-inflammatory, as well as anti-apoptotic effect of KMP-SeNPs. Immunohistochemical and histopathology results supported these molecular and biochemical findings to show approximately normal cardiac architecture. KMP-SeNPs are more effective in protecting against 5-FU-induced cardiotoxicity using antioxidant, anti-inflammatory, immunoregulatory, and anti-apoptotic activities.
No takes yet. Share an insight, caveat, or question.
Nasr et al. (2026) studied 5-fluorouracil-induced cardiotoxicity (n=35). Kaempferol-mediated selenium nanoparticles (KMP-SeNPs) vs. 5-fluorouracil (5-FU) alone was evaluated on Cardiac injury biomarkers (CK-MB, troponin, LDH) (p=<0.05). Kaempferol-mediated selenium nanoparticles significantly protected against 5-fluorouracil-induced cardiotoxicity, reducing CK-MB, troponin, and LDH levels by 40.67%, 40.03%, and 26.56% respectively compared to 5-FU alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: